Vital Signs Logo

Join Juan Valdez-Cappuccino and the BGB Medical Strategy Team as they explore the future of Alzheimer’s disease diagnosis and treatment. In this report, we highlight how AI-driven imaging and blood-based biomarkers are overcoming diagnostic challenges in Alzheimer’s care, offering unprecedented accuracy and speed.

AI-driven imaging in Alzheimer's

Get Social With Us